Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model
Neuroprotection has proven clinically unsuccessful in subarachnoid hemorrhage. We believe that this is because the major component in the early damage pathway, the vascular wall, has not been given the necessary focus. U0126 is a potent inhibitor of vascular phenotypical changes, exemplified by func...
Main Authors: | S. T. Christensen, A. S. Grell, S. E. Johansson, C. M. Andersson, L. Edvinsson, K. A. Haanes |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2019.1636421 |
Similar Items
-
Cremophor-Induced Lupus Erythematosus-Like Reaction with Taxol Administration: A Case Report and Review of the Literature
by: Anthony Q. Pham, et al.
Published: (2011-10-01) -
Antinociceptive effects of Cremophor EL orally administered to mice
by: Z. Tabarelli, et al.
Published: (2003-01-01) -
MEK1/2 Inhibition Synergistically Enhances the Preventive Effects of Normobaric Oxygen on Spinal Cord Injury in Decompression Sickness Rats
by: Quan Zhou, et al.
Published: (2021-06-01) -
Stability of Chlorophyll <i>a</i> Monomer Incorporated into Cremophor EL Nano-Micelles under Dark and Moderate Light Conditions
by: Ewa Janik-Zabrotowicz, et al.
Published: (2020-10-01) -
Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride
via Cremophor® El-Based Liquisolid Tablets
by: Soad Ali Yehia, et al.
Published: (2015-11-01)